ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diabetic Lancets Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-20Z7802
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Diabetic Lancets Market Insights and Forecast to 2028
BUY CHAPTERS

Global Diabetic Lancets Market Research Report 2025

Code: QYRE-Auto-20Z7802
Report
July 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Cardinal Health
LifeScan Inc
Arkray
Roche
BD
Ascensia
Abbott
B. Braun
Terumo
i-Sens
Nipro
ICU Medical
Sarstedt
Sinocare
Yicheng
Yuwell

Diabetic Lancets Market Size

The global market for Diabetic Lancets was valued at US$ 1201 million in the year 2024 and is projected to reach a revised size of US$ 1603 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Diabetic Lancets Market

Diabetic Lancets Market

A diabetic lancet is a small, sharp device used to prick the skin, typically the fingertip, to obtain a drop of blood for blood glucose testing. It is a key tool in diabetes management, allowing individuals with diabetes to regularly monitor their blood sugar levels. Lancets are often used with blood glucose meters and are designed to minimize pain and discomfort during testing. They are available in different sizes and needle thicknesses to suit various skin types and sensitivity levels.
Market Drivers:
Rising prevalence of diabetes: The global surge in diabetes cases, fueled by lifestyle changes, poor diets, and increasing obesity, has led to higher demand for blood sugar monitoring devices, including lancets.
Increased awareness about diabetes management: Governments and healthcare organizations are focusing on awareness campaigns about the importance of regular blood sugar monitoring, which boosts demand for self-monitoring devices and lancets.
Technological advancements: Continuous innovations in lancet design, such as painless, ultra-thin, and easy-to-use lancets, are attracting consumers who prefer comfortable and convenient blood sugar testing methods.
Aging population: Older adults are more prone to diabetes and require frequent blood sugar monitoring, thereby increasing the demand for lancets in healthcare settings.
Home healthcare trend: The growing preference for home-based healthcare and self-monitoring tools has led to a rise in the use of personal blood glucose monitoring systems, including lancets.
Increase in health expenditures: Higher healthcare spending by both individuals and governments is propelling the growth of diabetes-related products, especially in developing countries.
Market Challenges:
Risk of infections: Improper use of lancets or reusing them can lead to infections, which may deter some individuals from using these devices consistently.
Cost pressures: Lancet devices are often seen as a recurring expense for diabetes patients, which can be a financial burden, especially in low-income countries. This may limit market growth among economically disadvantaged populations.
Availability of alternatives: The development of non-invasive blood glucose monitoring systems (e.g., sensor-based or continuous glucose monitors) is a potential threat to lancet usage, as they reduce the need for frequent finger-pricking.
Regulatory hurdles: Stringent regulations and the need for approvals from healthcare authorities can slow down the launch of new and improved lancet technologies, limiting the pace of market growth.
Environmental concerns: Lancets are generally single-use items, and their disposal raises concerns about medical waste and environmental impact, which may affect their adoption if eco-friendliness becomes a critical factor for consumers or policymakers.
The classification of Lancets includes Ordinary Lancets and Safety Lancets. In 2023, Ordinary Lancets accounted for a share of 61.81% in the global Lancets market. With several hospitals and healthcare facilities converting to safety lancets, this market share is poised for declined. Americas is the largest consumption place, with a consumption market share nearly 40.77% in 2022. Following Americas, Europe is the second largest consumption place with the consumption market share of 30.34%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Diabetic Lancets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Lancets.
The Diabetic Lancets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetic Lancets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Lancets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Diabetic Lancets Market Report

Report Metric Details
Report Name Diabetic Lancets Market
Accounted market size in year US$ 1201 million
Forecasted market size in 2031 US$ 1603 million
CAGR 4.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Safety Lancets
  • Ordinary Lancets
Segment by Application
  • Hospital
  • Homecare
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Lifescan, BD, Ascensia, Abbott, B. Braun, ARKRAY, Terumo, I-SENS, Nipro, Cardinal Health, ICU Medical, Sarstedt, Sinocare, Yicheng, Yuwell
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Diabetic Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Diabetic Lancets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Diabetic Lancets Market growing?

Ans: The Diabetic Lancets Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Diabetic Lancets Market size in 2031?

Ans: The Diabetic Lancets Market size in 2031 will be US$ 1603 million.

What is the Diabetic Lancets Market share by type?

Ans: In 2023, Ordinary Lancets accounted for a share of 61.81% in the global Lancets market.

What is the Diabetic Lancets Market share by region?

Ans: Americas is the largest consumption place, with a consumption market share nearly 40.77% in 2022.

Who are the main players in the Diabetic Lancets Market report?

Ans: The main players in the Diabetic Lancets Market are Roche, Lifescan, BD, Ascensia, Abbott, B. Braun, ARKRAY, Terumo, I-SENS, Nipro, Cardinal Health, ICU Medical, Sarstedt, Sinocare, Yicheng, Yuwell

What are the Application segmentation covered in the Diabetic Lancets Market report?

Ans: The Applications covered in the Diabetic Lancets Market report are Hospital, Homecare, Other

What are the Type segmentation covered in the Diabetic Lancets Market report?

Ans: The Types covered in the Diabetic Lancets Market report are Safety Lancets, Ordinary Lancets

Recommended Reports

Glucose Monitoring

Diabetes Devices

Lancets & Accessories

1 Diabetic Lancets Market Overview
1.1 Product Definition
1.2 Diabetic Lancets by Type
1.2.1 Global Diabetic Lancets Market Value Comparison by Type (2024 VS 2031)
1.2.2 Safety Lancets
1.2.3 Ordinary Lancets
1.3 Diabetic Lancets by Application
1.3.1 Global Diabetic Lancets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Other
1.4 Global Diabetic Lancets Market Size Estimates and Forecasts
1.4.1 Global Diabetic Lancets Revenue 2020-2031
1.4.2 Global Diabetic Lancets Sales 2020-2031
1.4.3 Global Diabetic Lancets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Diabetic Lancets Market Competition by Manufacturers
2.1 Global Diabetic Lancets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Diabetic Lancets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Diabetic Lancets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Diabetic Lancets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diabetic Lancets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetic Lancets, Product Type & Application
2.7 Global Key Manufacturers of Diabetic Lancets, Date of Enter into This Industry
2.8 Global Diabetic Lancets Market Competitive Situation and Trends
2.8.1 Global Diabetic Lancets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Diabetic Lancets Players Market Share by Revenue
2.8.3 Global Diabetic Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Diabetic Lancets Market Scenario by Region
3.1 Global Diabetic Lancets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Diabetic Lancets Sales by Region: 2020-2031
3.2.1 Global Diabetic Lancets Sales by Region: 2020-2025
3.2.2 Global Diabetic Lancets Sales by Region: 2026-2031
3.3 Global Diabetic Lancets Revenue by Region: 2020-2031
3.3.1 Global Diabetic Lancets Revenue by Region: 2020-2025
3.3.2 Global Diabetic Lancets Revenue by Region: 2026-2031
3.4 North America Diabetic Lancets Market Facts & Figures by Country
3.4.1 North America Diabetic Lancets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Diabetic Lancets Sales by Country (2020-2031)
3.4.3 North America Diabetic Lancets Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diabetic Lancets Market Facts & Figures by Country
3.5.1 Europe Diabetic Lancets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Diabetic Lancets Sales by Country (2020-2031)
3.5.3 Europe Diabetic Lancets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetic Lancets Market Facts & Figures by Region
3.6.1 Asia Pacific Diabetic Lancets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Diabetic Lancets Sales by Region (2020-2031)
3.6.3 Asia Pacific Diabetic Lancets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diabetic Lancets Market Facts & Figures by Country
3.7.1 Latin America Diabetic Lancets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Diabetic Lancets Sales by Country (2020-2031)
3.7.3 Latin America Diabetic Lancets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetic Lancets Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetic Lancets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Diabetic Lancets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Diabetic Lancets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diabetic Lancets Sales by Type (2020-2031)
4.1.1 Global Diabetic Lancets Sales by Type (2020-2025)
4.1.2 Global Diabetic Lancets Sales by Type (2026-2031)
4.1.3 Global Diabetic Lancets Sales Market Share by Type (2020-2031)
4.2 Global Diabetic Lancets Revenue by Type (2020-2031)
4.2.1 Global Diabetic Lancets Revenue by Type (2020-2025)
4.2.2 Global Diabetic Lancets Revenue by Type (2026-2031)
4.2.3 Global Diabetic Lancets Revenue Market Share by Type (2020-2031)
4.3 Global Diabetic Lancets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Diabetic Lancets Sales by Application (2020-2031)
5.1.1 Global Diabetic Lancets Sales by Application (2020-2025)
5.1.2 Global Diabetic Lancets Sales by Application (2026-2031)
5.1.3 Global Diabetic Lancets Sales Market Share by Application (2020-2031)
5.2 Global Diabetic Lancets Revenue by Application (2020-2031)
5.2.1 Global Diabetic Lancets Revenue by Application (2020-2025)
5.2.2 Global Diabetic Lancets Revenue by Application (2026-2031)
5.2.3 Global Diabetic Lancets Revenue Market Share by Application (2020-2031)
5.3 Global Diabetic Lancets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Diabetic Lancets Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Lifescan
6.2.1 Lifescan Company Information
6.2.2 Lifescan Description and Business Overview
6.2.3 Lifescan Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lifescan Diabetic Lancets Product Portfolio
6.2.5 Lifescan Recent Developments/Updates
6.3 BD
6.3.1 BD Company Information
6.3.2 BD Description and Business Overview
6.3.3 BD Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BD Diabetic Lancets Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Ascensia
6.4.1 Ascensia Company Information
6.4.2 Ascensia Description and Business Overview
6.4.3 Ascensia Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ascensia Diabetic Lancets Product Portfolio
6.4.5 Ascensia Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Company Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Abbott Diabetic Lancets Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 B. Braun
6.6.1 B. Braun Company Information
6.6.2 B. Braun Description and Business Overview
6.6.3 B. Braun Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 B. Braun Diabetic Lancets Product Portfolio
6.6.5 B. Braun Recent Developments/Updates
6.7 ARKRAY
6.7.1 ARKRAY Company Information
6.7.2 ARKRAY Description and Business Overview
6.7.3 ARKRAY Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ARKRAY Diabetic Lancets Product Portfolio
6.7.5 ARKRAY Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Company Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Terumo Diabetic Lancets Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 I-SENS
6.9.1 I-SENS Company Information
6.9.2 I-SENS Description and Business Overview
6.9.3 I-SENS Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 I-SENS Diabetic Lancets Product Portfolio
6.9.5 I-SENS Recent Developments/Updates
6.10 Nipro
6.10.1 Nipro Company Information
6.10.2 Nipro Description and Business Overview
6.10.3 Nipro Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nipro Diabetic Lancets Product Portfolio
6.10.5 Nipro Recent Developments/Updates
6.11 Cardinal Health
6.11.1 Cardinal Health Company Information
6.11.2 Cardinal Health Description and Business Overview
6.11.3 Cardinal Health Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Cardinal Health Diabetic Lancets Product Portfolio
6.11.5 Cardinal Health Recent Developments/Updates
6.12 ICU Medical
6.12.1 ICU Medical Company Information
6.12.2 ICU Medical Description and Business Overview
6.12.3 ICU Medical Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.12.4 ICU Medical Diabetic Lancets Product Portfolio
6.12.5 ICU Medical Recent Developments/Updates
6.13 Sarstedt
6.13.1 Sarstedt Company Information
6.13.2 Sarstedt Description and Business Overview
6.13.3 Sarstedt Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sarstedt Diabetic Lancets Product Portfolio
6.13.5 Sarstedt Recent Developments/Updates
6.14 Sinocare
6.14.1 Sinocare Company Information
6.14.2 Sinocare Description and Business Overview
6.14.3 Sinocare Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sinocare Diabetic Lancets Product Portfolio
6.14.5 Sinocare Recent Developments/Updates
6.15 Yicheng
6.15.1 Yicheng Company Information
6.15.2 Yicheng Description and Business Overview
6.15.3 Yicheng Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Yicheng Diabetic Lancets Product Portfolio
6.15.5 Yicheng Recent Developments/Updates
6.16 Yuwell
6.16.1 Yuwell Company Information
6.16.2 Yuwell Description and Business Overview
6.16.3 Yuwell Diabetic Lancets Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Yuwell Diabetic Lancets Product Portfolio
6.16.5 Yuwell Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetic Lancets Industry Chain Analysis
7.2 Diabetic Lancets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetic Lancets Production Mode & Process Analysis
7.4 Diabetic Lancets Sales and Marketing
7.4.1 Diabetic Lancets Sales Channels
7.4.2 Diabetic Lancets Distributors
7.5 Diabetic Lancets Customer Analysis
8 Diabetic Lancets Market Dynamics
8.1 Diabetic Lancets Industry Trends
8.2 Diabetic Lancets Market Drivers
8.3 Diabetic Lancets Market Challenges
8.4 Diabetic Lancets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Cardinal Health
LifeScan Inc
Arkray
Roche
BD
Ascensia
Abbott
B. Braun
Terumo
i-Sens
Nipro
ICU Medical
Sarstedt
Sinocare
Yicheng
Yuwell
List of Tables
 Table 1. Global Diabetic Lancets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Diabetic Lancets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Diabetic Lancets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Diabetic Lancets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Diabetic Lancets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Diabetic Lancets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Diabetic Lancets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Diabetic Lancets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Diabetic Lancets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Diabetic Lancets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Diabetic Lancets, Product Type & Application
 Table 12. Global Key Manufacturers of Diabetic Lancets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Diabetic Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Lancets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Diabetic Lancets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Diabetic Lancets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Diabetic Lancets Sales Market Share by Region (2020-2025)
 Table 19. Global Diabetic Lancets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Diabetic Lancets Sales Market Share by Region (2026-2031)
 Table 21. Global Diabetic Lancets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Diabetic Lancets Revenue Market Share by Region (2020-2025)
 Table 23. Global Diabetic Lancets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Diabetic Lancets Revenue Market Share by Region (2026-2031)
 Table 25. North America Diabetic Lancets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Diabetic Lancets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Diabetic Lancets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Diabetic Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Diabetic Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Diabetic Lancets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Diabetic Lancets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Diabetic Lancets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Diabetic Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Diabetic Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Diabetic Lancets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Diabetic Lancets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Diabetic Lancets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Diabetic Lancets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Diabetic Lancets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Diabetic Lancets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Diabetic Lancets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Diabetic Lancets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Diabetic Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Diabetic Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Diabetic Lancets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Diabetic Lancets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Diabetic Lancets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Diabetic Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Diabetic Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Diabetic Lancets Sales (K Units) by Type (2020-2025)
 Table 51. Global Diabetic Lancets Sales (K Units) by Type (2026-2031)
 Table 52. Global Diabetic Lancets Sales Market Share by Type (2020-2025)
 Table 53. Global Diabetic Lancets Sales Market Share by Type (2026-2031)
 Table 54. Global Diabetic Lancets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Diabetic Lancets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Diabetic Lancets Revenue Market Share by Type (2020-2025)
 Table 57. Global Diabetic Lancets Revenue Market Share by Type (2026-2031)
 Table 58. Global Diabetic Lancets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Diabetic Lancets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Diabetic Lancets Sales (K Units) by Application (2020-2025)
 Table 61. Global Diabetic Lancets Sales (K Units) by Application (2026-2031)
 Table 62. Global Diabetic Lancets Sales Market Share by Application (2020-2025)
 Table 63. Global Diabetic Lancets Sales Market Share by Application (2026-2031)
 Table 64. Global Diabetic Lancets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Diabetic Lancets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Diabetic Lancets Revenue Market Share by Application (2020-2025)
 Table 67. Global Diabetic Lancets Revenue Market Share by Application (2026-2031)
 Table 68. Global Diabetic Lancets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Diabetic Lancets Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Diabetic Lancets Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Lifescan Company Information
 Table 76. Lifescan Description and Business Overview
 Table 77. Lifescan Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Lifescan Diabetic Lancets Product
 Table 79. Lifescan Recent Developments/Updates
 Table 80. BD Company Information
 Table 81. BD Description and Business Overview
 Table 82. BD Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BD Diabetic Lancets Product
 Table 84. BD Recent Developments/Updates
 Table 85. Ascensia Company Information
 Table 86. Ascensia Description and Business Overview
 Table 87. Ascensia Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ascensia Diabetic Lancets Product
 Table 89. Ascensia Recent Developments/Updates
 Table 90. Abbott Company Information
 Table 91. Abbott Description and Business Overview
 Table 92. Abbott Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Abbott Diabetic Lancets Product
 Table 94. Abbott Recent Developments/Updates
 Table 95. B. Braun Company Information
 Table 96. B. Braun Description and Business Overview
 Table 97. B. Braun Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. B. Braun Diabetic Lancets Product
 Table 99. B. Braun Recent Developments/Updates
 Table 100. ARKRAY Company Information
 Table 101. ARKRAY Description and Business Overview
 Table 102. ARKRAY Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. ARKRAY Diabetic Lancets Product
 Table 104. ARKRAY Recent Developments/Updates
 Table 105. Terumo Company Information
 Table 106. Terumo Description and Business Overview
 Table 107. Terumo Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Terumo Diabetic Lancets Product
 Table 109. Terumo Recent Developments/Updates
 Table 110. I-SENS Company Information
 Table 111. I-SENS Description and Business Overview
 Table 112. I-SENS Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. I-SENS Diabetic Lancets Product
 Table 114. I-SENS Recent Developments/Updates
 Table 115. Nipro Company Information
 Table 116. Nipro Description and Business Overview
 Table 117. Nipro Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Nipro Diabetic Lancets Product
 Table 119. Nipro Recent Developments/Updates
 Table 120. Cardinal Health Company Information
 Table 121. Cardinal Health Description and Business Overview
 Table 122. Cardinal Health Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Cardinal Health Diabetic Lancets Product
 Table 124. Cardinal Health Recent Developments/Updates
 Table 125. ICU Medical Company Information
 Table 126. ICU Medical Description and Business Overview
 Table 127. ICU Medical Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. ICU Medical Diabetic Lancets Product
 Table 129. ICU Medical Recent Developments/Updates
 Table 130. Sarstedt Company Information
 Table 131. Sarstedt Description and Business Overview
 Table 132. Sarstedt Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Sarstedt Diabetic Lancets Product
 Table 134. Sarstedt Recent Developments/Updates
 Table 135. Sinocare Company Information
 Table 136. Sinocare Description and Business Overview
 Table 137. Sinocare Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Sinocare Diabetic Lancets Product
 Table 139. Sinocare Recent Developments/Updates
 Table 140. Yicheng Company Information
 Table 141. Yicheng Description and Business Overview
 Table 142. Yicheng Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Yicheng Diabetic Lancets Product
 Table 144. Yicheng Recent Developments/Updates
 Table 145. Yuwell Company Information
 Table 146. Yuwell Description and Business Overview
 Table 147. Yuwell Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Yuwell Diabetic Lancets Product
 Table 149. Yuwell Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Diabetic Lancets Distributors List
 Table 153. Diabetic Lancets Customers List
 Table 154. Diabetic Lancets Market Trends
 Table 155. Diabetic Lancets Market Drivers
 Table 156. Diabetic Lancets Market Challenges
 Table 157. Diabetic Lancets Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Diabetic Lancets
 Figure 2. Global Diabetic Lancets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Diabetic Lancets Market Share by Type: 2024 & 2031
 Figure 4. Safety Lancets Product Picture
 Figure 5. Ordinary Lancets Product Picture
 Figure 6. Global Diabetic Lancets Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Diabetic Lancets Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Homecare
 Figure 10. Other
 Figure 11. Global Diabetic Lancets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Diabetic Lancets Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Diabetic Lancets Sales (2020-2031) & (K Units)
 Figure 14. Global Diabetic Lancets Average Price (US$/Unit) & (2020-2031)
 Figure 15. Diabetic Lancets Report Years Considered
 Figure 16. Diabetic Lancets Sales Share by Manufacturers in 2024
 Figure 17. Global Diabetic Lancets Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Diabetic Lancets Players: Market Share by Revenue in Diabetic Lancets in 2024
 Figure 19. Diabetic Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Diabetic Lancets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Diabetic Lancets Sales Market Share by Country (2020-2031)
 Figure 22. North America Diabetic Lancets Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Diabetic Lancets Sales Market Share by Country (2020-2031)
 Figure 26. Europe Diabetic Lancets Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Diabetic Lancets Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Diabetic Lancets Revenue Market Share by Region (2020-2031)
 Figure 34. China Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Diabetic Lancets Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Diabetic Lancets Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Diabetic Lancets Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Diabetic Lancets Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Diabetic Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Diabetic Lancets by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Diabetic Lancets by Type (2020-2031)
 Figure 56. Global Diabetic Lancets Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Diabetic Lancets by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Diabetic Lancets by Application (2020-2031)
 Figure 59. Global Diabetic Lancets Price (US$/Unit) by Application (2020-2031)
 Figure 60. Diabetic Lancets Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Diabetes Devices and Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Care Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetic Eye Disease Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Wearables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Home Use Lancets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Digital Diabetes Care Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Disposable Blood Lancet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Glucose Meters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Management Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Food for Special Diets for Diabetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Networked Glucose Meter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digital Diabetes Tools Market Research Report 2025
Global Diabetic Injection Instrument Market Research Report 2025
Portable Blood Glucose Meter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hemoglobin A1c Testing Devices for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Blood Collection Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetes Testing Kit Market Research Report 2024
Sterile Blood Lancet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
HbA1c Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetic Sensor Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions